Kevin Yau
Overview
Explore the profile of Kevin Yau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
386
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Calvaruso L, Yau K, Akbari P, Nasri F, Khowaja S, Wang B, et al.
Sci Rep
. 2023 Dec;
13(1):22257.
PMID: 38097698
Tolvaptan is the first disease-modifying drug proven to slow eGFR decline in high-risk patients with ADPKD. However, barriers from the patient perspective to its use in real-life settings have not...
12.
Di Meo A, Ma L, Yau K, Abe K, Colwill K, Gingras A, et al.
Clin Biochem
. 2023 Nov;
121-122:110681.
PMID: 37913837
Background: Hemodialysis patients exhibit variable immunogenicity following administration of the SARS-CoV-2 mRNA vaccine. The aim of the current study was to evaluate the use of two commercial assays in the...
13.
Yau K, Tam P, Chan C, Hu Q, Qi F, Abe K, et al.
Clin J Am Soc Nephrol
. 2023 Oct;
19(1):85-97.
PMID: 37847518
Background: There is a lack of randomized controlled trial data regarding differences in immunogenicity of varying coronavirus disease 2019 (COVID-19) mRNA vaccine regimens in CKD populations. Methods: We conducted a...
14.
Yau K, Kurtesi A, Qi F, Delgado-Brand M, Tursun T, Hu Q, et al.
Nat Commun
. 2023 Sep;
14(1):6041.
PMID: 37758707
Neutralization of Omicron subvariants by different bivalent vaccines has not been well evaluated. This study characterizes neutralization against Omicron subvariants in 98 individuals on dialysis or with a kidney transplant...
15.
Yau K, Wang C, Al Batran R, MacPhee A, Beaucage M, Farragher J
Can J Kidney Health Dis
. 2023 Aug;
10:20543581231191839.
PMID: 37637870
Purpose Of Review: Glomerulonephritis refers to a rare group of diseases characterized by glomerular inflammation, which collectively are a common cause of kidney failure. Until recently, there was a lack...
16.
Yau K, Odutayo A, Dash S, Cherney D
Can J Cardiol
. 2023 Jul;
39(12):1816-1838.
PMID: 37429523
Glucagon-like peptide-1 receptor agonists (GLP1RA) are incretin agents initially designed for the treatment of type 2 diabetes mellitus but because of pleiotropic actions are now used to reduce cardiovascular disease...
17.
Yau K, McArthur E, Jeyakumar N, Tsobo Muanda F, Kim R, Clemens K, et al.
Health Sci Rep
. 2023 Jun;
6(6):e1375.
PMID: 37359413
Background And Aims: Quetiapine is an atypical antipsychotic predominantly metabolized by the cytochrome P450 3A4 (CYP3A4) enzyme. We studied the risk of adverse events following coprescription of clarithromycin (a strong...
18.
19.
Yau K, Jeyakumar N, Kang Y, Dixon S, Freeman M, Garg A, et al.
J Am Soc Nephrol
. 2023 Apr;
34(7):1155-1158.
PMID: 37022115
Nephrologist staffing models for patients receiving hemodialysis vary widely. Patients may be cared for continuously by a single primary nephrologist or by a group of nephrologists on a rotating basis....
20.
Yau K, Enilama O, Levin A, Romney M, Singer J, Blake P, et al.
Can J Kidney Health Dis
. 2023 Mar;
10:20543581231160511.
PMID: 36950028
Background: People living with chronic kidney disease (CKD) have been disproportionately affected by the coronavirus disease 2019 (COVID-19) pandemic, including higher rates of infection, hospitalization, and death. Data on responsiveness...